Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-13 5:30 pm Purchase | 2024-09-30 | 13G | BIOMX INC PHGE | Nantahala Capital Management, LLC | 94,428 9.990% | 94,428 (New Position) | Filing History |
| 2024-11-13 5:14 pm Purchase | 2024-09-30 | 13G | BIOMX INC PHGE | AMR Action Fund L.P. | 46,152 4.900% | 30,074 (+187.05%) | Filing History |
| 2024-11-04 4:05 pm Purchase | 2024-09-30 | 13G | BIOMX INC PHGE | Burbank John Howard III | 26,853 2.900% | 2,652 (+10.96%) | Filing History |
| 2024-10-28 4:01 pm Purchase | 2024-09-30 | 13G | BIOMX INC UNIT 1 COM & 1 WT EX PHGEU | Rodney Hodges | 560,267 3.100% | 276,296 (+97.30%) | Filing History |
| 2024-07-17 8:40 pm Purchase | 2024-07-15 | 13D | BIOMX INC PHGE | OrbiMed Israel BioFund GP Limited Partnership | 94,093 9.990% | 27,894 (+42.14%) | Filing History |
| 2024-07-11 6:47 pm Purchase | 2024-07-09 | 13D | BIOMX INC PHGE | Flynn James E | 818,866 9.990% | 786,708 (+2446.38%) | Filing History |
| 2024-05-30 7:26 pm Unchanged | 2024-05-30 | 13D | BIOMX INC PHGE | Flynn James E | 32,158 8.750% | 0 (Unchanged) | Filing History |
| 2024-03-26 4:30 pm Purchase | 2024-03-26 | 13G | BIOMX INC PHGE | Cystic Fibrosis Foundation | 49,108 15.600% | 25,148 (+104.96%) | Filing History |
| 2024-03-25 3:35 pm Purchase | 2024-03-15 | 13G | BIOMX INC PHGE | AMR Action Fund L.P. | 16,078 5.500% | 16,078 (New Position) | Filing History |
| 2024-03-22 5:44 pm Purchase | 2024-03-15 | 13D | BIOMX INC PHGE | Flynn James E | 32,158 11.060% | 32,158 (New Position) | Filing History |
| 2024-03-19 9:11 pm Purchase | 2024-03-15 | 13D | BIOMX INC PHGE | OrbiMed Israel BioFund GP Limited Partnership | 66,199 19.900% | 41,979 (+173.32%) | Filing History |
| 2024-03-08 4:30 pm Purchase | 2024-03-06 | 13D | BIOMX INC PHGE | OrbiMed Israel BioFund GP Limited Partnership | 24,220 9.900% | 254 (+1.06%) | Filing History |
| 2024-02-13 1:09 pm Sale | 2023-12-31 | 13G | BIOMX INC PHGE | MMCAP International Inc. SPC | 8,042 3.220% | -3,657 (-31.26%) | Filing History |
| 2024-02-02 5:07 pm Sale | 2023-12-31 | 13G | BIOMX INC PHGE | JOHNSON & JOHNSON JNJ | 11,123 4.600% | -105 (-0.94%) | Filing History |
| 2024-01-30 4:05 pm Purchase | 2024-01-30 | 13G | BIOMX INC PHGE | Cystic Fibrosis Foundation | 23,960 9.900% | 9,481 (+65.48%) | Filing History |
| 2023-09-29 09:20 am Purchase | 2023-05-04 | 13G | BIOMX INC PHGE | Rodney Hodges | 14,946 6.200% | 14,946 (New Position) | Filing History |
| 2023-06-23 4:50 pm Purchase | 2023-05-04 | 13G | BIOMX INC PHGE | Burbank John Howard III | 24,201 9.990% | 24,201 (New Position) | Filing History |
| 2023-05-08 4:43 pm Purchase | 2023-05-04 | 13D | BIOMX INC PHGE | OrbiMed Israel BioFund GP Limited Partnership | 23,966 9.900% | 5,353 (+28.76%) | Filing History |
| 2023-03-17 4:19 pm Purchase | 2023-02-27 | 13D | BIOMX INC PHGE | OrbiMed Israel BioFund GP Limited Partnership | 18,613 10.500% | 6,558 (+54.40%) | Filing History |
| 2023-03-08 5:22 pm Purchase | 2023-02-27 | 13G | BIOMX INC PHGE | Cystic Fibrosis Foundation | 14,479 8.100% | 14,479 (New Position) | Filing History |